The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
about
Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients.Individual and Combined Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients.DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcomaCCAR2 Is Required for Proliferation and Tumor Maintenance in Human Squamous Cell Carcinoma.CCAR2 negatively regulates IL-8 production in cervical cancer cells.The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma.
P2860
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
@ast
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
@en
type
label
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
@ast
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
@en
prefLabel
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
@ast
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
@en
P2093
P2860
P1476
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
@en
P2093
Kyoung Kim
Myoung Chung
Myoung Kang
See-Hyoung Park
P2860
P2888
P356
10.1186/S13048-015-0129-3
P577
2015-02-15T00:00:00Z
P5875
P6179
1034304705